Results 111 to 120 of about 10,636 (185)

Assessment of neuroleptic-induced movement disorders in a naturalistic schizophrenia population [PDF]

open access: yes, 2006
The prevalence and assessment of neuroleptic-induced movement disorders (NIMDs) in a naturalistic schizophrenia population that uses conventional neuroleptics were studied.
Janno, Sven
core  

Neuroleptic malignant syndrome and subsequent clozapine-withdrawal effects in a patient with refractory schizophrenia

open access: yesNeuropsychiatric Disease and Treatment, 2016
Minfeng Cheng,* Huaying Gu,* Liangrong Zheng, Houliang Wang, Zhiyong Zhong, Shenglin Wen Department of Psychiatry, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, People’s Republic of China *These authors contributed equally ...
Cheng M   +5 more
doaj  

Malignant neuroleptic syndrome associated with the use of antipsychotic drugs [PDF]

open access: yes, 2017
Trabajo fin de grado en EnfermeríaINTRODUCCIÓN: El Síndrome Neuroléptico Maligno (SNM) es la complicación más grave asociada al uso de agentes que alteran la neurotransmisión del sistema dopaminérgicos, como antipsicóticos y/o antagonistas de la dopamina.
Mateos Martínez, María Alicia   +1 more
core  

Recognizing and managing a malignant hyperthermia crisis: guidelines from the European Malignant Hyperthermia Group [PDF]

open access: yes, 2017
Survival from a malignant hyperthermia (MH) crisis is highly dependent on early recognition and prompt action. MH crises are very rare and an increasing use of total i.v.
Ellis, F. R.   +6 more
core  

Neuroleptic Malignant Syndrome: A Case Report of the Oldest Man in Literature. [PDF]

open access: yesClin Case Rep
Elyasi F   +4 more
europepmc   +1 more source

Olanzapine-Induced Diabetic Ketoacidosis and Neuroleptic Malignant Syndrome: A Case Report. [PDF]

open access: yesCureus
Almahmood M   +6 more
europepmc   +1 more source

Antipsychotic medication for people with first episode schizophrenia: an exploratory economic analysis of alternative treatment algorithms [PDF]

open access: yes
Available clinical evidence suggests that the newer antipsychotics are similar to conventional antipsychotics for positive symptom control. It has been suggested that they may also be superior for negative symptoms and side effects, but the evidence for ...
Linda Davies, Shon Lewis
core  

Home - About - Disclaimer - Privacy